MERS-CoV Genomic Surveillance Reveals a Thin and Uneven Global Genome Record
The global genomic record for Middle East respiratory syndrome coronavirus remains heavily weighted toward the early years of detection, with public curated sequences rising sharply through the middle of the last decade and then tapering to a sparse trickle. The figure assembled for 2012 through 2025 makes that pattern unmistakable: 8 sequences in 2012, 69 in 2013, 115 in 2014, and a peak of 320 in 2015, followed by a decline that never fully recovers to that level. By 2020, only 1 sequence was available, followed by 3 in 2021, 7 in 2022, 35 in 2023, 15 in 2024, and 2 in 2025.
The surveillance curve is not just a tally. It is the genomic footprint of an outbreak ecology that has remained geographically concentrated, difficult to sample consistently, and dependent on continued sequencing capacity across countries and host species.
A Sequence Archive Dominated by Earlier Years
The sharp early concentration of genomes matters because genomic surveillance is most informative when sequence flow is continuous. In the MERS-CoV dataset summarized here, the public archive builds quickly after the first detections and then becomes discontinuous, leaving long stretches where the virus is represented by very few genomes. Such gaps complicate efforts to map transmission chains, identify introductions into new settings, and track whether viral diversification is occurring quietly outside the most intensively sampled periods.
For a virus with known zoonotic and nosocomial relevance, sparse modern sequencing leaves public health with a partial view. A small sequence count does not prove reduced circulation; it may simply reflect less sampling, fewer submissions, or both. The virus can continue to move through human and animal interfaces while the genomic record grows only intermittently.
The figure’s country-level breakdown reinforces that point. Sequence availability varies widely by nation, and the total number attached to each country is uneven. The visual emphasis on World Health Organization regions shows the center of gravity remains in the Eastern Mediterranean Region, with additional contributions from Africa, Asia, Europe, and the Western Pacific. The pattern is consistent with a pathogen whose persistence is tied to regional exposure networks rather than broad global endemicity.
Host Sampling Still Centers on a Narrow Biological Interface
The host distribution is equally important. The figure tracks proportions of sequences by host, and that lens is essential for a virus that crosses between animals and humans. Surveillance of MERS-CoV is not only a matter of counting human cases; it depends on understanding what is happening in animal reservoirs and at the human-animal boundary. When host sampling is narrow, the virus’s evolutionary trajectory can appear flatter than it really is.
MERS-CoV remains a pathogen where genomic change can influence outbreak investigation even when the total number of sequences is modest. Sequence comparison can distinguish related clusters from unrelated introductions, identify clade patterns, and show whether a given detection sits within a familiar lineage or represents a separate event. The curated genome record is therefore more than an archive. It is the basis for interpreting whether cases reflect repeated spillover, silent spread, or local amplification.
A single clade A sequence from the United Arab Emirates in 2015 is marked separately in the figure, a reminder that individual genomes can still matter in a broader surveillance map dominated by one heavily sampled year. Small anomalies can be epidemiologically useful when the dataset is limited. In sparse surveillance systems, one well-placed genome can clarify a local finding that would otherwise remain ambiguous.
Why the 2015 Peak Still Shapes Interpretation
The 2015 surge in available genomes sets the baseline against which the later years look thin. With 320 sequences recorded that year, the archive captures a period of intense genomic attention that stands apart from the rest of the timeline. Later years never recreate that density. The drop to 75 in 2016 and 86 in 2017 is substantial, and the decline continues through 2018, 2019, and the pandemic years that follow.
The public health implication is straightforward. Genome databases can create a false sense of completeness when the visual archive is dense in one period and sparse in another. For MERS-CoV, the result is a data record that may overrepresent one phase of surveillance intensity while underrepresenting ongoing viral activity in the years that followed. That imbalance complicates comparisons across time and can bias how clinicians, laboratorians, and epidemiologists interpret apparent trends.
Even with these limitations, the figure still offers a usable signal. The distribution of sequences by year, host, clade, and country shows where surveillance has been strongest and where it has thinned out. It also shows that global genomic monitoring for MERS-CoV is not a static task; it requires sustained sampling, curated submission, and cross-border coordination if the archive is to remain clinically and epidemiologically meaningful.
Gaps in the Archive Leave Core Questions Open
The most consequential limitation is visible in plain sight: recent years contain very few genomes. With only 1 sequence in 2020, 3 in 2021, 7 in 2022, 35 in 2023, 15 in 2024, and 2 in 2025, the present-day record is too small to support any confident claim about global evolutionary stability or change. Those numbers are descriptive, not definitive. They tell us what has been deposited publicly, not what may have circulated undetected.
For a pathogen that continues to demand vigilance from respiratory and travel medicine systems, that distinction is operationally important. Genomic surveillance works best when it is broad, continuous, and linked to case investigation. Here, the sequence archive instead looks intermittent, with long flat stretches broken by surges in attention. The biology of MERS-CoV has not disappeared; the depth of its genomic observation has simply become uneven.
The next interpretive step depends on filling those gaps with more regular sequence collection from humans and relevant animal hosts. Without that, the public record will remain a fragmented map of a virus that still demands coherent surveillance across regions and years.